Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × daromun × Clear all

Phase

Status

Unknown 1 Recruiting 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Cyclophosphamide 1287 Cisplatin 1227 Radiotherapy 1159 Paclitaxel 1155 Carboplatin 1090 Gemcitabine 1065 Docetaxel 988 Bevacizumab 928 Fluorouracil 783 Doxorubicin 695 Capecitabine 661 Dexamethasone 655 Rituximab 644 Oxaliplatin 613 Etoposide 585 pembrolizumab 572 Irinotecan 559 Filgrastim 543 Leucovorin 511 Cytarabine 506 Nivolumab 483 Vincristine 441 Bortezomib 420 Cetuximab 416 Prednisone 411 Erlotinib Hydrochloride 404 Trastuzumab 402 Surveys and Questionnaires 390 Methotrexate 372 Lenalidomide 369

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02076633 2015-05-27

Intratumoral Administration of L19IL2/L19TNF

Philogen S.p.A.

Phase 2 Completed

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡